D-0277-2024 Class I Ongoing
FDA drug recall D-0277-2024 was initiated by Denver Solutions, LLC DBA Leiters Health on Dec 28, 2023 and is designated Class I. Reason for recall: Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags. The recall status is ongoing. Affected quantity: 8,976 IV bags.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 7, 2024
- Initiation Date
- Dec 28, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8,976 IV bags
Product description
FentaNYL citrate PF, 1000 mcg per 100 mL 0.9% Sodium Chloride (10 mcg per mL), Item F3355, for IV use only; Leiters 13796 Compark Blvd Englewood, CO 80112; NDC 71449-072-41.
Reason for recall
Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.
Distribution pattern
Nationwide within the United States
Code information
Lot #: 2331062, Exp. Date: 02/08/2024; 2331224, Exp. Date 03/18/2024; 2331270, Exp. Date 03/28/2024.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0277-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026